Global trends in health research and development expenditures - the challenge of making reliable estimates for international comparison

Health Research Policy and Systems

Volumn 13, Issue 1, 2015, Pages

  Young, Alison J ^a   Terry, Robert F ^b   Røttingen, John Arne ^c,d,e   Viergever, Roderik F ^f,g  

^a OECD   (France)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Health financing; Health research; Research and development; Research and development deflators; Research and development exchange rates; Research funding; Research methods

Indexed keywords

ANALYTIC METHOD; ASIA; AUSTRALIA; CANADA; COMPARATIVE STUDY; DEVELOPED COUNTRY; HEALTH CARE COST; HEALTH STATISTICS; HUMAN; INDIA; JAPAN; MANUFACTURING INDUSTRY; MEDICAL RESEARCH; NATIONAL HEALTH ORGANIZATION; NOTE; SOUTH KOREA; UNITED STATES; CULTURAL FACTOR; DEVELOPING COUNTRY; ECONOMICS; HEALTH; HEALTH CARE POLICY; INFORMATION PROCESSING; INTERNATIONAL COOPERATION; PROCEDURES; RESEARCH; TRENDS;

BIOMEDICAL RESEARCH; CROSS-CULTURAL COMPARISON; DATA COLLECTION; DEVELOPING COUNTRIES; GLOBAL HEALTH; HEALTH EXPENDITURES; HEALTH POLICY; HUMANS; INTERNATIONALITY; RESEARCH;

EID: 84928715001     PISSN: None     EISSN: 14784505     Source Type: Journal    
DOI: 10.1186/1478-4505-13-7     Document Type: Note

References (15)

1. Young AJ, Terry RF, Røttingen J-A, Viergever RF: Global biomedical R&D expenditures. N Engl J Med 2014,370(25):2451.
2. OECD: Annex 4 R&D Related to Health, Information Technology and Biotechnology. The measurement of scientific and technological activities. Frascati Manual 2002. Proposed standard practice for surveys on research and experimental development 2002, 181-7.
3. OECD: Annex 9 R&D Deflators and Currency Converters. The Measurement of Scientific and Technological Activities. Frascati Manual 2002. Proposed Standard Practice for Surveys on Research and Experimental Development 2002, 217-25.
4. Chakma J, Sun GH, Steinberg JD, Sammut SM, Jagsi R: Asia's ascent - global trends in biomedical R&D expenditures. N Engl J Med 2014,370(1):3-6. 10.1056/NEJMp1311068
5. Røttingen JA, Regmi S, Young AJ, Viergever RF, Årdal C, Guzman J, et al.: Mapping of available health research and development data: what's there, what's missing and what role is there for a global observatory? Lancet 2013,382(9900):1286-307. 10.1016/S0140-6736(13)61046-6
6. Boroush M, Moris FA: Chapter 4 Research and Development: National Trends and International Comparisons. In Science and Engineering Indicators. Arlington, VA: National Science Board; 2014:..
7. Eurostat-OECD: UROSTAT-OECD Methodological manual on purchasing power parities. Luxembourg: Publications Office of the European Union; 2012.
8. Dougherty SM, Inklaar R, McGuckin RH, van Ark BI: International comparisons of R&D expenditure: does an R&D PPP make a difference?. Cambridge, MA: National Bureau of Economics; 2007. http://www.nber.org/papers/w12829
9. NIH: Biomedical Research and Development Price Index (BRDPI): Fiscal Year 2012 Update and Projections for FY 2013-FY 2018. Bethesda, USA: National Institutes of Health; 2013.
10. Messinis G: Patent Quality and R&D Productivity in Pharmaceuticals: The Role of Inflation and International Collaboration. Working Paper no. 27. Melbourne: VIC: Centre for Strategic Economic Studies, Victoria University of Technology; 2005. http://vises.org.au/documents/pharma/27-Patent_Quality_and_R&D_Productivity.pdf
11. Shackelford B: Health and Defense Applications Account for 40% of Business R&D in the United States. Arlington, VA: National Centre for Science and Engineering Studies; National Science Foundation; 2012.
12. OECD: Chapter 6 Measurement of Expenditures Devoted to R&D. The Measurement of Scientific and Technological Activities: Proposed Standard Practice for Surveys on Research and Experimental Development Frascati Manual 2002. Reconciling Differences in Performer-Based and Source-Based Reporting 2002, 119-20.
13. United Nations: International Monetary Fund, World Bank, OECD, European Commission. System of National Accounts 2008. New York: UN; 2009.
14. Terry R: Establishing a Global Observatory for Health R&D - Meeting the Challenge. Geneva: WHO; 2013. Accessed 7 March 20 http://www.who.int/phi/implementation/phi_rd_observatory/en/
15. Terry RF, Salm JF Jr, Nannei C, Dye C: Creating a global observatory for health R&D. Science 2014,345(6202):1302-4. 10.1126/science.1258737